Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Current Assets (2020 - 2025)

Historic Current Assets for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to $325.9 million.

  • Maravai Lifesciences Holdings' Current Assets fell 5201.76% to $325.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $325.9 million, marking a year-over-year decrease of 5201.76%. This contributed to the annual value of $429.1 million for FY2024, which is 3868.57% down from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Current Assets of $325.9 million as of Q3 2025, which was down 5201.76% from $359.8 million recorded in Q2 2025.
  • Over the past 5 years, Maravai Lifesciences Holdings' Current Assets peaked at $847.9 million during Q4 2022, and registered a low of $325.9 million during Q3 2025.
  • In the last 5 years, Maravai Lifesciences Holdings' Current Assets had a median value of $681.5 million in 2024 and averaged $628.7 million.
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Current Assets skyrocketed by 12317.35% in 2021, and later plummeted by 5201.76% in 2025.
  • Quarter analysis of 5 years shows Maravai Lifesciences Holdings' Current Assets stood at $740.0 million in 2021, then grew by 14.58% to $847.9 million in 2022, then dropped by 17.45% to $699.9 million in 2023, then crashed by 38.69% to $429.1 million in 2024, then fell by 24.07% to $325.9 million in 2025.
  • Its Current Assets stands at $325.9 million for Q3 2025, versus $359.8 million for Q2 2025 and $376.3 million for Q1 2025.